• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.

作者信息

Cohen B I, Hofmann A F, Mosbach E H, Stenger R J, Rothschild M A, Hagey L R, Yoon Y B

出版信息

Gastroenterology. 1986 Jul;91(1):189-97. doi: 10.1016/0016-5085(86)90457-9.

DOI:10.1016/0016-5085(86)90457-9
PMID:3710068
Abstract

Nor-ursodeoxycholate, the C23 analogue of ursodeoxycholate, is a potent choleretic agent in rodents when given acutely but, to be used in humans, chronic toxicity studies are required. In the rabbit, ingestion of ursodeoxycholate or chenodeoxycholate leads to accumulation of lithocholate, its major bacterial metabolite, in biliary bile acids, which causes inflammation in portal tracts of the liver and bile duct proliferation. To test whether chronic administration of nor-ursodeoxycholate would cause an analogous accumulation of nor-lithocholate and hepatotoxicity, rabbits were fed a Chow diet containing nor-ursodeoxycholate (5 or 50 mg/day): control groups received Chow alone, and "disease control" groups received Chow plus ursodeoxycholate or Chow plus chenodeoxycholate. After 3 wk, animals were killed, liver sections were interpreted by a pathologist, and the steroid moiety of the glycine (and taurine) conjugates of gallbladder bile acids were analyzed by high-pressure liquid chromatography. Ingestion of nor-ursodeoxycholate did not cause hepatotoxicity, and neither it nor its presumed metabolite, nor-lithocholate, accumulated in biliary bile acids. To explain this unexpected finding, the hepatic metabolism of nor-ursodeoxycholate was investigated in biliary fistula rabbits. Nor-ursodeoxycholate was well absorbed from the intestine and secreted in the bile as a glucuronide as well as the unchanged compound, but conjugation with glycine and taurine was not observed. As glucuronides are poorly absorbed from the gut, it is proposed that the hepatic biotransformation of nor-ursodeoxycholate to a glucuronide rather than to a glycine amidate in the liver prevented its accumulation in the bile acid pool. Thus, shortening the side chain of ursodeoxycholate by a single carbon atom resulted in a bile acid with novel metabolism, which when administered chronically, does not accumulate in the enterohepatic circulation and does not cause hepatotoxicity.

摘要

相似文献

1
Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
Gastroenterology. 1986 Jul;91(1):189-97. doi: 10.1016/0016-5085(86)90457-9.
2
Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.兔体内胆汁酸的肝毒性:熊去氧胆酸的毒性低于鹅去氧胆酸。
Lab Invest. 1982 Apr;46(4):428-37.
3
Prevention of ursodeoxycholate hepatotoxicity in the rabbit by conjugation with N-methyl amino acids.
Hepatology. 1990 Jun;11(6):989-96. doi: 10.1002/hep.1840110613.
4
Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.侧链缩短对胆汁酸生理特性的影响:啮齿动物肝脏转运及对23-去甲熊去氧胆酸胆汁分泌的影响
Gastroenterology. 1986 Apr;90(4):837-52. doi: 10.1016/0016-5085(86)90859-0.
5
Effects of sodium ursodeoxycholate, hyodeoxycholate and dehydrocholate on cholesterol and bile acid metabolism in rats.熊去氧胆酸钠、猪去氧胆酸和脱氢胆酸对大鼠胆固醇和胆汁酸代谢的影响。
J Pharmacobiodyn. 1983 May;6(5):346-57. doi: 10.1248/bpb1978.6.346.
6
Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation.
Gastroenterology. 1988 Aug;95(2):454-63. doi: 10.1016/0016-5085(88)90504-5.
7
The ursodeoxycholate dose-dependent formation of ursodeoxycholate-glucuronide in the rat and the choleretic potencies.熊去氧胆酸在大鼠体内剂量依赖性地形成熊去氧胆酸葡萄糖醛酸苷及其利胆效能。
Hepatology. 1990 May;11(5):743-9. doi: 10.1002/hep.1840110506.
8
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者口服牛磺熊去氧胆酸的代谢情况
Gut. 1996 Mar;38(3):439-46. doi: 10.1136/gut.38.3.439.
9
Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.熊去氧胆酸保护氧化线粒体代谢免受胆汁酸毒性影响:大鼠离体肝线粒体的剂量反应研究
Hepatology. 1994 Dec;20(6):1595-601. doi: 10.1002/hep.1840200632.
10
Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate.
Gastroenterology. 1995 Aug;109(2):564-72. doi: 10.1016/0016-5085(95)90346-1.

引用本文的文献

1
Bile acid therapy for primary biliary cholangitis: Pathogenetic validation.原发性胆汁性胆管炎的胆汁酸疗法:发病机制验证。
World J Exp Med. 2025 Mar 20;15(1):101771. doi: 10.5493/wjem.v15.i1.101771.
2
The changing metabolic landscape of bile acids - keys to metabolism and immune regulation.胆汁酸不断变化的代谢格局——代谢与免疫调节的关键
Nat Rev Gastroenterol Hepatol. 2024 Jul;21(7):493-516. doi: 10.1038/s41575-024-00914-3. Epub 2024 Apr 4.
3
Biology of Cholangiocytes: From Bench to Bedside.胆管细胞生物学:从 bench 到 bedside 。 (注:bench 常表示基础研究阶段,bedside 常表示临床应用阶段,这里表示从基础研究到临床应用)
Gut Liver. 2016 Sep 15;10(5):687-98. doi: 10.5009/gnl16033.
4
A review of the medical treatment of primary sclerosing cholangitis in the 21st century.21世纪原发性硬化性胆管炎的医学治疗综述。
Ther Adv Chronic Dis. 2016 Jan;7(1):68-85. doi: 10.1177/2040622315605821.
5
Functional and structural features of cholangiocytes in health and disease.健康与疾病状态下胆管细胞的功能和结构特征
Cell Mol Gastroenterol Hepatol. 2015 Jul 1;1(4):368-380. doi: 10.1016/j.jcmgh.2015.05.005.
6
Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis.去甲熊去氧胆酸与熊去氧胆酸对硫代乙酰胺诱导的大鼠肝纤维化的保护作用
J Clin Exp Hepatol. 2014 Dec;4(4):293-301. doi: 10.1016/j.jceh.2014.02.001. Epub 2014 Feb 21.
7
Differential effects of norUDCA and UDCA in obstructive cholestasis in mice.熊去氧胆酸和熊去氧胆酸在小鼠梗阻性胆汁淤积中的差异作用。
J Hepatol. 2013 Jun;58(6):1201-8. doi: 10.1016/j.jhep.2013.01.026. Epub 2013 Jan 29.
8
Activation of muscarinic receptor signaling by bile acids: physiological and medical implications.胆汁酸对毒蕈碱受体信号的激活作用:生理及医学意义
Dig Dis Sci. 2003 Aug;48(8):1431-44. doi: 10.1023/a:1024733500950.
9
Unexpected dilatation of the common bile duct after methyl tertiary butyl ether (MTBE) in rabbits. Possible implications to findings in man.
Gut. 1989 Feb;30(2):206-12. doi: 10.1136/gut.30.2.206.
10
Current concepts of biliary secretion.
Dig Dis Sci. 1989 Dec;34(12 Suppl):16S-20S. doi: 10.1007/BF01536657.